The TSC Conference 2020 is taking place in Sydney on 2 and 3 May. This is a unique opportunity to find out more about TSC, latest treatments and research and to meet other people living with TSC and expert TSC health professionals. Registrations are now open.
Dr Darcy Krueger (pictured), Director of the Tuberous Sclerosis Clinic and Associate Professor of Clinical Pediatrics and Neurology at Cincinnati Children’s Hospital Medical Center, will be the keynote speaker. Dr Krueger will join local and national experts in discussing the diagnosis and management of TSC with topics including epilepsy, autism and the evolution of new treatments such as mTOR inhibitors and cannaboids. The conference, which only takes place every four or five years, has two streams – one for people affected by TSC (TSC Community) and another for TSC Health Professionals. To find out more and to register, click here.
About Tuberous Sclerosis Complex (TSC)
TSC affects more than 2,000 individuals in Australia and thousands more carers, families and friends who live with the impact of the disease. TSC tumours can grow in any organ of the body, commonly affecting the brain, skin, heart, lungs and kidneys. TSC can cause epilepsy, developmental delay and autism. There is no known cure, but with appropriate support most people with TSC can live fulfilling lives.Donate Now
Tuberous Sclerosis Australia (TSA) empowers people affected by TSC through access to the best treatment options, up to date information and support.
Support TSA. We want to improve the lives of Australians living with TSC but can only do so with your support. Please consider making a tax deductible donation today.
You are invited to join Genetic Alliance, Sanofi Genzyme and Syndromes without a name for an evening of discussion and interaction with the rare disease community. Those impacted by rare diseases often experience significant health, psychosocial, economic burdens and... Read More
TSC Research Round Up is a new enewsletter from TSA in which we present summary reports of some of the latest TSC-related research from Australia and around the world that we believe may be of relevance and importance to... Read More
Many people contact our TSA Nurse to say that they have trouble finding a GP who has experience with the health needs of someone with TSC, and that this can lead them to feel frustrated and isolated. Here are... Read More
Dr Kate Riney and the team at Queensland Children’s Hospital are currently recruiting patients for a formal phase II/III trial of topical rapamycin (sirolimus) for facial angiofibromas. Some funding for interstate travel is available, making this trial available for... Read More